Patent details

EP1677823 Title: BOTULINUM TOXIN TREATMENTS OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS

Basic Information

Publication number:
EP1677823
PCT Application Number:
PCT/US/2004/035592
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP048215875
PCT Publication Number:
WO/2005/084705
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BOTULINUM TOXIN TREATMENTS OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS
French Title of Invention:
TRAITEMENTS A BASE DE TOXINE BOTULINIQUE CONTRE LES TROUBLES NEUROLOGIQUES ET NEUROPSYCHIATRIQUES
German Title of Invention:
BEHANDLUNGEN MIT BOTULINUM TOXIN VON NEUROLOGISCHE UND NEUROPSYCHIATRISCHE KRANKHEITEN
SPC Number:

Dates

Filing date:
26/10/2004
Grant date:
22/10/2008
EP Publication Date:
22/10/2008
PCT Publication Date:
15/09/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/07/2006
EP B1 Publication Date:
22/10/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/10/2008
Expiration date:
26/10/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/10/2004
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

Name:
BLUMENFELD Andrew, M.
Address:
United States (US)

Priority

1

Priority Number:
515362 P
Priority Date:
29/10/2003
Priority Country:
United States (US)

2

Priority Number:
556150 P
Priority Date:
24/03/2004
Priority Country:
United States (US)

3

Priority Number:
574957 P
Priority Date:
26/05/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/08;
Filing date Document type Number of pages